JLE

Médecine

MENU

Gout: Historical and pathophysiological data Volume 15, issue 6, Juin 2019

  • [1] Leca A-P. In: R. Da Costa (ed.). Histoire illustrée de la Rhumatologie, Paris, 1982.
  • [2] Vidal F. La polyvalence thérapeutique de la saignée. http://www.biusante.parisdescartes.fr/sfhad/vol1/art04/article.htm.
  • [3] Copeman W.S.C. A short history of the gout and the rheumatic diseases. Berkeley and Los Angeles: University of California Press; 1964.
  • [4] Fagot-Largeault A. Quelques implications de la recherche étiologique. Sciences Sociales et Santé. 1992;X:33-45.
  • [5] Roddy E., Doherty M. Gout. Epidemiology of gout. Arthritis Res Ther. 2010;12:223.
  • [6] So A., Thorens B. Uric acid transport and disease. J Clin Invest. 2010;120:1791-1799.
  • [7] Roddy E. Revisiting the pathogenesis of podagra: why does gout target the foot? J Foot Ankle Res. 2011;4:13.
  • [8] Emmerson B.T., Nagel S.L., Duffy D.L., Martin N.G. Genetic control of the renal clearance of urate: a study of twins. Ann Rheum Dis. 1992;51:375-377.
  • [9] So A., Thorens B. Uric acid transport and disease. J Clin Invest. 2010;120:1791-1799.
  • [10] Roddy E., Choy H.K. Epidemilology of gout. Rheum Dis Clin North Am. 2014;40:155-175.
  • [11] Urano W., Taniguchi A., Anzai N., Inoue E., Kanai Y., Yamanaka M., Endou H., Kamatani N., Yamanaka H. Sodium-dependent phosphate cotransporter type 1 sequence polymorphisms in male patients with gout. Ann Rheum Dis. 2010;69:1232-1234.